Click HERE for Important Information for Licensees struggling with mental health or substance abuse issues.
***SCAM ALERT!!! - All licensees be aware of an ongoing scam. A licensee may receive a call from a person impersonating an investigator, board member, or another government agency official. The call may come from a random cell phone number or spoofing the Division of Professional Regulation’s main phone number of (302) 744-4500. Click HERE for more information.***
If you are unable to reach us by phone, submit your inquiry via email at customerservice.dpr@delaware.gov. More Info
Welcome to the Delaware Prescription Monitoring Program (PMP). The Delaware Prescription Monitoring Act (16 Del. C.§ 4798) authorizes the Office of Controlled Substances (OCS) in the Delaware Division of Professional Regulation to establish, maintain and monitor the PMP. The purpose of the PMP is to reduce misuse of controlled substances in Delaware and to promote improved professional practice and patient care.
The PMP is a system that collects information on all controlled substance (schedules II-V) prescriptions. Using the PMP website, Delaware-licensed pharmacies and prescribers who dispense controlled substances report prescription data to the PMP daily. Prescribers and dispensers registered with the PMP can obtain immediate access to an online report of their current or prospective patient’s controlled substance prescription history. This PMP website is available 24/7 and is to be used for healthcare purposes only.
The objective of the PMP Advisory Committee is to provide input, advice, and guidance to the OCS about the maintenance of the PMP.
All Committee meetings are open to the general public. They are usually held in the Buena Vista Conference Center, 661 S. Dupont Hwy., Buck Library, 1st Floor, New Castle, DE 19720, but the location is subject to change. Check the meeting calendar to confirm dates and location.
To ensure that business is on the agenda for the Committee to consider at its next meeting, submit all documentation to the Committee office no later than 4:30 PM ten full working days before the meeting date.
Related Topics: controlled substances, delaware, Department of State, PMP, prescription, Prescription Monitoring Program, State of Delaware